No profile data available.
Kodiak Sciences Inc. (KOD) is a healthcare company in the eye treatment pharmaceuticals industry, based in Palo Alto, United States, with about 141 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$229.97 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $6.28 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.
Kodiak Sciences reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$6.28 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (eye treatment pharmaceuticals) include Regeneron Pharmaceuticals, Inc. (REGN), Belite Bio, Inc (BLTE), Bausch + Lomb Corporation (BLCO), MeiraGTx Holdings plc (MGTX).